- Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
- The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
- The company has also tested the same on previously identified six genome mutations.
- The company will conduct a 2nd-phase trial of the antibody cocktail with CT-P....
Tags : SOUTH KOREA COVID-19 TREATMENT, SOUTH KOREA PHARMACEUTICAL COMPANY, CELLTRION INC., CT-P59 TREATMENT, BRITAIN COVID-19 VARIANT, SOUTH KOREA COVID-19 VARIANT,